Novel Nucleobase–2-Oxindole–Heterocyclic Hybrids as Selective Cell Cycle Regulators with Potential Anticancer Activities

Faculty of Pharmacy

Assiut University

Novel Nucleobase–2-Oxindole–Heterocyclic Hybrids as Selective Cell Cycle Regulators with Potential Anticancer Activities

Research Authors
Gehan Ahmed Abdel-Hafez1, Dagmara Kłopotowska, Beata Filip-Psurska, Ahmed S. Aboraia, Joanna Wietrzyk, Adel F. Youssef, Tarek Aboul-Fadl
Research Date
Research Department
Department of Medicinal Chemistry
Research Journal
12th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2025)
Research Publisher
Magnus Group LLC
Research Website
https://pharmaceuticsconference.com/speaker/tarek-aboul-fadl
Research Year
2025
Research Member
Tarek Aboul-Fadl Mohammad Hassan
Adel Fawzy Yousef Mohiel-Deen
Ahmed Safwat Mohamed Aboraia